Physician profile
Jeffrey C Stone
NPI 1124177977
$6,312.82
in general payments reported to CMS, 2019-2025
18 companies · $2,089 in 2025
The $2,089 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $261 · 2021: $143 · 2022: $1,846 · 2023: $1,526 · 2024: $232 · 2025: $2,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,286 · Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,286.12 |
| Food and Beverage | $1,560.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $1,568.78 | 2021-2023 | Fna Products |
| Medical Device Business Services, INC. | $1,493.82 | 2020-2025 | Motoband |
| Treace Medical Concepts, INC. | $1,180.23 | 2022-2025 | |
| Horizon Therapeutics Plc | $466.97 | 2019-2023 | Krystexxa |
| Kerecis Limited | $422.29 | 2020-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $237.79 | 2020-2025 | Collagenase Santyl, Grafix Pl, Pico |
| Stryker Corporation | $234.83 | 2022-2023 | Prophecy, Ortholoc 2 Lapifuse, Ortholoc 3di Crosscheck |
| Depuy Synthes Sales INC. | $189.96 | 2024-2025 | Na |
| Abbvie INC. | $100.22 | 2021-2023 | Dalvance |
| Amgen INC. | $87.78 | 2024-2025 | Krystexxa |
| Heron Therapeutics, INC. | $79.81 | 2021-2023 | Zynrelef |
| Paratek Pharmaceuticals, INC. | $70.00 | 2024-2025 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $58.88 | 2022-2023 | Seglentis |
| Orthofix Medical, INC. | $30.24 | 2020-2021 | |
| Misonix INC | $27.00 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $25.51 | 2019 | |
| Organogenesis INC. | $23.74 | 2019 | |
| Aroa Biosurgery Incorporated | $14.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.